RecruitingNCT06728969

A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.

Device studyAges 6–17United States

The study in practice

Understand this study

Listed age limits: 6 years to 17 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: June 2, 2024

Recruitment status: Recruiting
Enrollment listed in the registry: 120
Sponsor: MindTension
Sponsor type: Unknown or unclear
Study type: Device
Intervention type: DEVICE
Study phase: Not clearly listed
Locations: United States
Age range: From 6 Years to 17 Years
Official registry ID: NCT06728969
Official title: Show the full official title
A Prospective Comparative Study to Evaluate a Novel Algorithm Using Data Derived from a Non-Invasive Digital Biomarker As a Diagnostic Aid for ADHD in Youth Ages 6-17.

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Recruiting

New York

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is MindTension.

Who can participate?

Listed age limits: 6 years to 17 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.